Comparison between botulinum toxin and corticosteroid injection in the treatment of acute and subacute tennis elbow: A prospective, randomized, double-blind, active drug-controlled pilot study

American Journal of Physical Medicine and Rehabilitation

Volumn 89, Issue 8, 2010, Pages 653-659

  Lin, Yu Ching ^a,b,c   Tu, Yuan Kun ^a,b   Chen, Sheng Shiung ^a   Lin, I Ling ^f   Chen, Shih Ching ^d,e   Guo, How Ran ^c,g,h  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Botulinum Toxin Type A; Corticosteroid; Humeral Lateral Epicondylitis; Tennis Elbow

Indexed keywords

BOTULINUM TOXIN A; CORTICOSTEROID; MUSCLE RELAXANT AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAND STRENGTH; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PAIN ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TENNIS ELBOW;

ADRENAL CORTEX HORMONES; ADULT; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HAND STRENGTH; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; PILOT PROJECTS; PROSPECTIVE STUDIES; TENNIS ELBOW; TRIAMCINOLONE ACETONIDE;

EID: 77955046115     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3181cf564d     Document Type: Article

References (29)

1. Ritz BR: Humeral epicondylitis among gas- and waterworks employees. Scand J Work Environ Health 1995;21:478-486
2. Darmawan J, Valkenburg HA, Muirden KD, et al: The prevalence of soft tissue rheumatism. A whoilar copcord study. Rheumatol Int 1995;15:121-124
3. Nirschl RP: Elbow tendinosis/tennis elbow. Clin Sports Med 1992;11:851-870
4. Smidt N, van der Windt DA, Assendelft WJ, et al: Corticosteroid injections, physiotherapy, or a wait and see policy for lateral epicondylitis: A randomized controlled trial. Lancet 2002;359:657-662
5. Sevier TL, Wilson JK: Treating lateral epicondylitis. Sports Med 1999;28:375-380
6. Tonks JH, Pai SK, Murali SR: Steroid injection therapy is the best conservative treatment for lateral epicondylitis: A prospective randomised controlled trial. Int J Clin Pract 2007;61:240-246
7. Labelle H, Guibert R, Joncas J, et al: Lack of scientific evidence for the treatment of lateral epicondylitis of the elbow. An attempted meta-analysis. J Bone Joint Surg Br 1992;74:646-651
8. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194
9. Argoff CE: A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002; 18(suppl 6):S177-81
10. Binder WJ, Brin MF, Blitzer A, et al: Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study. Otolaryngol Head Neck Surg 2000;123:669-676
11. Freund BJ, Schwartz M: Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study. Headache 2000;40:231-236 (Pubitemid 30169888)
12. Foster L, Clapp L, Erickson M, et al: Botulinum toxin A and chronic low back pain: A randomized, double- blind study. Neurology 2001;56:1290-1293
13. Morre HH, Keizer SB, van Os JJ: Treatment of chronic tennis elbow with botulinum toxin. Lancet 1997;349:1746
14. Keizer SB, Rutten HP, Pilot P, et al: Botulinum toxin injection versus surgical treatment for tennis elbow: A randomized pilot study. Clin Orthop Relat Res 2002;401:125-131
15. Wong SM, Hui AC, Tong PY, et al: Treatment of lateral epicondylitis with botulinum toxin. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2005;143:793-797
16. Hayton MJ, Santini AJ, Hughes PJ, et al: Botulinum toxin injection in the treatment of tennis elbow. A double-blind, randomized, controlled pilot study. J Bone Joint Surg Am 2005;87:503-507
17. Stratford P, Levy D, Gowland C: Evaluative properties of measures used to assess patients with lateral epicondylitis. Physiother Can 1993;45:160-164
18. Stratford PW, Levy DR: Assessing valid change over time in patients with lateral epicondylitis at the elbow. Clin J Sport Med 1994;4:88-91
19. Scott J, Huskisson EC: Graphic representation of pain. Pain 1976;2:175-184
20. Yao G, Chung CW, Yu CF, et al: Development and verification of validity and reliability of the WHO- QOL-BREF Taiwan version. J Formos Med Assoc 2002;101:342-351
21. Horng YS, Hwang YH, Wu HC, et al: Predicting health-related quality of life in patients with low back pain. Spine (Phila Pa 1976) 2005;30:551-555
22. Brin MF: Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 1997; 6:S146-68
23. Ishikawa H, Mitsui Y, Yoshitomi T, et al: Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 2000;44:106-109
24. Welch MJ, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000;38: 245-258
25. Cui M, Khanijou S, Rubino J, et al: Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107:125-133
26. Dolly JO, Aoki KR: The structure and mode of action of different botulinum toxins. Eur J Neurol 2006; 13(suppl 4):1-9
27. Namazi H: A novel molecular mechanism to account for the action of botulinum toxin against lateral epicondylitis. Int J Rheum Dis 2008;11:83-84
28. Pullman SL: The myriad uses of botulinum toxin. Ann Intern Med 2005;143:838-839
29. Placzek R, Drescher W, Deuretzbacher G, et al: Treatment of chronic radial epicondylitis with botulinum toxin A. J Bone Joint Surg Am 2007;89:255-260.